| review article | Q7318358 |
| scholarly article | Q13442814 |
| P2093 | author name string | Henry D Perry | |
| P433 | issue | 3 Suppl | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | diagnosis | Q16644043 |
| pathophysiology | Q1135939 | ||
| eye disease | Q3041498 | ||
| P304 | page(s) | S79-87 | |
| P577 | publication date | 2008-04-01 | |
| P1433 | published in | American Journal of Managed Care | Q15807020 |
| P1476 | title | Dry eye disease: pathophysiology, classification, and diagnosis | |
| P478 | volume | 14 |
| Q43118320 | A Crosslinked HA-Based Hydrogel Ameliorates Dry Eye Symptoms in Dogs |
| Q30956506 | A metabolomic approach to dry eye disorders. The role of oral supplements with antioxidants and omega 3 fatty acids |
| Q35176597 | A review on recent advances in dry eye: Pathogenesis and management |
| Q64092315 | Acupuncture and dry eye: current perspectives. A double-blinded randomized controlled trial and review of the literature |
| Q37458867 | Characteristics of respondents with glaucoma and dry eye in a national panel survey |
| Q39799778 | Cis-urocanic acid suppresses UV-B-induced interleukin-6 and -8 secretion and cytotoxicity in human corneal and conjunctival epithelial cells in vitro. |
| Q33908655 | Development and validation of the Chinese version of dry eye related quality of life scale |
| Q35717311 | Development and validation of the impact of dry eye on everyday life (IDEEL) questionnaire, a patient-reported outcomes (PRO) measure for the assessment of the burden of dry eye on patients |
| Q30833462 | Differential effects of dry eye disorders on metabolomic profile by 1H nuclear magnetic resonance spectroscopy |
| Q34144866 | Discrepancy between subjectively reported symptoms and objectively measured clinical findings in dry eye: a population based analysis |
| Q33734208 | Dry eye reversal and corneal sensation restoration with topical naltrexone in diabetes mellitus |
| Q34974140 | Effect of reactive oxygen species generation in rabbit corneal epithelial cells on inflammatory and apoptotic signaling pathways in the presence of high osmotic pressure |
| Q37464380 | Effectiveness and tolerability of dietary supplementation with a combination of omega-3 polyunsaturated fatty acids and antioxidants in the treatment of dry eye symptoms: results of a prospective study |
| Q36613855 | Effects of a nutraceutical formulation based on the combination of antioxidants and ω-3 essential fatty acids in the expression of inflammation and immune response mediators in tears from patients with dry eye disorders. |
| Q30435051 | Efficacy and patient tolerability of travoprost BAK-free solution in patients with open-angle glaucoma and ocular hypertension |
| Q34273267 | Essential fatty acids in the treatment of dry eye syndrome: A myth or reality? |
| Q34130406 | Establishing human lacrimal gland cultures with secretory function. |
| Q38822811 | Evaluation of Accessory Lacrimal Gland in Muller's Muscle Conjunctival Resection Specimens for Precursor Cell Markers and Biological Markers of Dry Eye Disease |
| Q36358739 | How to promote and preserve eyelid health |
| Q42572882 | Molecular mechanism of ocular surface damage: application to an in vitro dry eye model on human corneal epithelium |
| Q34476408 | Non-invasive in vivo measurement of the tear film using spatial autocorrelation in a live mammal model |
| Q34318892 | Ocular surface alterations and topical antiglaucomatous therapy: a review |
| Q48240182 | Ocular surface assessment in patients with obstructive sleep apnea-hypopnea syndrome |
| Q37708674 | Oxidative stress and its downstream signaling in aging eyes. |
| Q36444344 | PERSIST: Physician's Evaluation of Restasis(®) Satisfaction in Second Trial of topical cyclosporine ophthalmic emulsion 0.05% for dry eye: a retrospective review |
| Q36957699 | Patients undergoing long-term treatment with antihypertensive eye drops responded positively with respect to their ocular surface disorder to oral supplementation with antioxidants and essential fatty acids. |
| Q91827428 | Real-World Treatment Patterns Of Cyclosporine Ophthalmic Emulsion And Lifitegrast Ophthalmic Solution Among Patients With Dry Eye |
| Q37316518 | Sjögren's syndrome-like ocular surface disease in thrombospondin-1 deficient mice |
| Q37900496 | Systane lubricant eye drops in the management of ocular dryness |
| Q37354938 | Tear Production Rate in a Mouse Model of Dry Eye According to the Phenol Red Thread and Endodontic Absorbent Paper Point Tear Tests |
| Q38270449 | The role and treatment of inflammation in dry eye disease |
| Q37307601 | Vitamin D Supplementation for Patients with Dry Eye Syndrome Refractory to Conventional Treatment. |
Search more.